600511 Stock Overview
China National Medicines Corporation Ltd., together with its subsidiaries, distributes pharmaceutical products in China.
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 1/6 |
Past Performance | 5/6 |
Financial Health | 6/6 |
Dividends | 5/6 |
China National Medicines Corporation Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥34.83 |
52 Week High | CN¥44.80 |
52 Week Low | CN¥26.58 |
Beta | 0.37 |
1 Month Change | 10.99% |
3 Month Change | 13.42% |
1 Year Change | -14.00% |
3 Year Change | 0.81% |
5 Year Change | 40.27% |
Change since IPO | 27.58% |
Recent News & Updates
Recent updates
Shareholder Returns
600511 | CN Healthcare | CN Market | |
---|---|---|---|
7D | -1.6% | -0.9% | -0.4% |
1Y | -14.0% | -33.5% | -14.4% |
Return vs Industry: 600511 exceeded the CN Healthcare industry which returned -33.5% over the past year.
Return vs Market: 600511 matched the CN Market which returned -14.4% over the past year.
Price Volatility
600511 volatility | |
---|---|
600511 Average Weekly Movement | 4.4% |
Healthcare Industry Average Movement | 6.8% |
Market Average Movement | 8.8% |
10% most volatile stocks in CN Market | 12.7% |
10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 600511 has not had significant price volatility in the past 3 months.
Volatility Over Time: 600511's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1999 | 3,138 | Guotao Tian | www.cncm.com.cn |
China National Medicines Corporation Ltd., together with its subsidiaries, distributes pharmaceutical products in China. The company also manufactures and sells new drugs and finished drugs; sells Chinese patent medicines and western medicines, and medical equipment; and offers warehousing and import and export agency services. It serves hospitals, retail pharmacies, and medical institutions.
China National Medicines Corporation Ltd. Fundamentals Summary
600511 fundamental statistics | |
---|---|
Market cap | CN¥26.28b |
Earnings (TTM) | CN¥2.15b |
Revenue (TTM) | CN¥49.70b |
12.2x
P/E Ratio0.5x
P/S RatioIs 600511 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
600511 income statement (TTM) | |
---|---|
Revenue | CN¥49.70b |
Cost of Revenue | CN¥45.70b |
Gross Profit | CN¥3.99b |
Other Expenses | CN¥1.85b |
Earnings | CN¥2.15b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 26, 2024
Earnings per share (EPS) | 2.84 |
Gross Margin | 8.03% |
Net Profit Margin | 4.32% |
Debt/Equity Ratio | 1.5% |
How did 600511 perform over the long term?
See historical performance and comparison